Most Clicked StoriesMore >


Bayer suspends radium-223 production

SNMMI SmartBrief | Oct 17, 2014

Bayer HealthCare Pharmaceuticals has halted production of prostate cancer drug radium-223, sold as Xofigo, because of problems with manufacturing. Supplies of the drug have been limited since Oct. 7, according to the FDA. Bayer said it is communicating with the FDA and providers about the issue, but it had no estimate regarding when production will resume. OncLive (10/15)


Brain SPECT could help improve psychiatric disorder outcomes

SNMMI SmartBrief | Oct 13, 2014

Technique mitigates effects of breathing during PET, data suggest

SNMMI SmartBrief | Oct 14, 2014

Review finds SPECT and PET useful in ischemic stroke management

SNMMI SmartBrief | Oct 16, 2014

Study IDs sensitive brain areas where networks come together

SNMMI SmartBrief | Oct 15, 2014

Research traces chain of events that leads to Alzheimer's

SNMMI SmartBrief | Oct 14, 2014

N.H. breast-imaging device startup obtains $6.5M

SNMMI SmartBrief | Oct 17, 2014

Agents show promise in colorectal cancer detection

SNMMI SmartBrief | Oct 17, 2014

SNMMI urges members to speak out on proposed imaging standards

SNMMI SmartBrief | Oct 14, 2014

Upcoming webinar -- Updates on Ga-68: Outlook for the Future

SNMMI SmartBrief | Oct 15, 2014


Find SNMMI SmartBrief Issues by Date:



SNMMI News More >


"Updates on Ga-68: Outlook for the Future" webinar Thursday at 3 p.m. ET

SNMMI SmartBrief | Oct 20, 2014

Ebola: What you should know about management and response

SNMMI SmartBrief | Oct 20, 2014

Online registration is now available for the SNMMI 2015 Mid-Winter Meeting

SNMMI SmartBrief | Oct 17, 2014

Now available: PET Online Review Workshop. VOICE credit available

SNMMI SmartBrief | Oct 17, 2014

Need money? Apply now for SNMMI grants, awards and scholarships

SNMMI SmartBrief | Oct 16, 2014




Sign up for SNMMI SmartBrief



Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession. Learn more